Authors
Katie R Conover, Sarah A Taylor
Published in
Clinics in liver disease. Volume 30. Issue 4. Pages 975-985. Epub Aug 28, 2026.
Abstract
Gestational alloimmune liver disease (GALD) is a top cause of neonatal acute liver failure that is highly preventable in subsequent pregnancies after the index case. The understood mechanism involves placental passage of maternal antibodies targeting an unknown fetal hepatocyte antigen, leading to complement activation and extensive hepatocyte damage and fibrosis. This disease mechanism explains the clinical presentation of liver failure shortly after birth. Intravenous immunoglobulin and double volume exchange transfusion can improve neonatal outcomes, likely due to dampening the effect of circulating maternal antibodies. Early recognition of GALD depends on a high index of clinical suspicion.
PMID:
42946528
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0